Carlyle, PAI said to near $1.4 billion deal for CVC’s Theramex

Carlyle, PAI said to near $1.4 billion deal for CVC’s Theramex

Bloomberg: Carlyle Group Inc. and PAI Partners are nearing an agreement to buy women’s health business Theramex from private equity firm CVC Capital Partners, according to people familiar with the matter.

The consortium of Carlyle and PAI could announce the acquisition of London-based Theramex for about $1.4 billion as early as Monday, the people said, asking not to be identified because the matter is private. The duo outbid other suitors for the specialty pharmaceutical company, the people said.

Representatives for Carlyle, PAI and CVC declined to comment.

CVC has been exploring a sale of Theramex in a deal that could value the business at more than $1 billion and drew interest from other buyout groups seeking to bolster their health-care portfolios, Bloomberg News reported in January.